We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+17.37%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$140M
AUM Growth
+$22.6M
Cap. Flow
+$4.69M
Cap. Flow %
3.36%
Top 10 Hldgs %
25.46%
Holding
159
New
26
Increased
30
Reduced
50
Closed
18

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.14M
2
INTC icon
Intel
INTC
+$1.72M
3
CIEN icon
Ciena
CIEN
+$1.18M
4
LLY icon
Eli Lilly
LLY
+$1.16M
5
PEP icon
PepsiCo
PEP
+$844K

Sector Composition

Rank Sector Weight
1 Healthcare 23.84%
2 Technology 20.82%
3 Consumer Staples 15.19%
4 Industrials 14.56%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$5.76M 4.12%
74,525
+550
+0.7% +$40K
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$4.91M 3.51%
34,889
CSCO icon
3
Cisco
CSCO
$457B
$4.41M 3.16%
94,650
-5,400
-5% -$237K
AAPL icon
4
Apple
AAPL
$4.54T
$4.02M 2.88%
44,096
-140
-0.3% -$10.8K
MSFT icon
5
Microsoft
MSFT
$3.45T
$2.99M 2.14%
14,709
KMB icon
6
Kimberly-Clark
KMB
$36.3B
$2.94M 2.1%
20,788
PFE icon
7
Pfizer
PFE
$143B
$2.72M 1.95%
87,597
+19,288
+28% +$655K
MRK icon
8
Merck
MRK
$322B
$2.71M 1.94%
36,753
+9,274
+34% +$698K
UPS icon
9
United Parcel Service
UPS
$88.6B
$2.69M 1.92%
24,175
+700
+3% +$69.9K
ABT icon
10
Abbott
ABT
$183B
$2.43M 1.74%
26,553
ZTS icon
11
Zoetis
ZTS
$32.4B
$2.36M 1.69%
17,198
-450
-3% -$58.8K
KO icon
12
Coca-Cola
KO
$377B
$2.34M 1.67%
52,325
-300
-0.6% -$13.8K
BMY icon
13
Bristol-Myers Squibb
BMY
$133B
$2.3M 1.65%
39,137
+3,800
+11% +$227K
CSX icon
14
CSX Corp
CSX
$93.4B
$2.24M 1.6%
96,225
WASH icon
15
Washington Trust Bancorp
WASH
$743M
$2.14M 1.53%
65,455
-5,593
-8% -$183K
LDOS icon
16
Leidos
LDOS
$14.5B
$2.11M 1.51%
+22,479
New +$2.21M
VZ icon
17
Verizon
VZ
$195B
$2.04M 1.46%
37,060
+12,700
+52% +$714K
HON icon
18
Honeywell
HON
$77B
$1.76M 1.26%
12,930
+5,013
+63% +$663K
CVS icon
19
CVS Health
CVS
$133B
$1.66M 1.19%
25,500
-700
-3% -$44.1K
UNP icon
20
Union Pacific
UNP
$174B
$1.64M 1.17%
9,680
-369
-4% -$59.1K
PG icon
21
Procter & Gamble
PG
$336B
$1.61M 1.16%
13,501
GIS icon
22
General Mills
GIS
$19.1B
$1.51M 1.08%
24,425
-500
-2% -$30.2K
INTC icon
23
Intel
INTC
$455B
$1.5M 1.07%
25,013
-28,714
-53% -$1.72M
NKE icon
24
Nike
NKE
$61.9B
$1.48M 1.06%
15,060
-925
-6% -$85.4K
GOOGL icon
25
Alphabet (Google) Class A
GOOGL
$4.36T
$1.45M 1.04%
20,460

Similar funds

New England Research & Management's Q2 2020 Portfolio in Review

As of Q2 2020, New England Research & Management held 159 positions worth $140M, up 19% from $117M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

New England Research & Management deployed $4.69M of net new capital in Q2 2020, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Leidos: 22,479 shares worth $2.11M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Walt Disney, an estimated $2.14M trimmed.

  • New England Research & Management's largest Q2 2020 buy was Leidos: 22,479 shares worth $2.11M.
  • New England Research & Management added most to Waste Management in Q2 2020, an estimated $947K increase.
  • New England Research & Management's biggest Q2 2020 reduction was Walt Disney, cutting an estimated $2.14M.
  • New England Research & Management fully exited Ciena in Q2 2020, selling an estimated $1.18M.
  • New England Research & Management's ten largest holdings make up 25% of its $140M portfolio in Q2 2020.
  • New England Research & Management opened 26 new positions and closed 18 in Q2 2020.
  • New England Research & Management's portfolio value rose 19% quarter-over-quarter to $140M.

Based on New England Research & Management's 13F filing for Q2 2020, filed 15 Jul 2020.